ADAC Laboratories reported last week that it was expecting topost revenues of about $44 million for its first fiscal quarter(end-January), down slightly from the $46.5 million registeredin the same period last year. Earnings per share will be
ADAC Laboratories reported last week that it was expecting topost revenues of about $44 million for its first fiscal quarter(end-January), down slightly from the $46.5 million registeredin the same period last year. Earnings per share will be about15¢ a share, compared to 23¢ per share in the firstquarter of 1994.
The figures meet ADAC's expectations for the quarter, accordingto president and CEO David Lowe. ADAC, of Milpitas, CA, also saidit is progressing in its negotiations to acquire parts of CommunityHealth Computing, the radiology information systems vendor thatfiled for Chapter 11 last month (SCAN 12/14/94).
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.